In The News

Apr 4, 2023 Kazia Therapeutics to present new pipeline molecule data at AACR 2023

Mar 6, 2023 Kazia Therapeutics forms clinical collaboration for Australian Phase 2 study of paxalisib, targeting childhood cancers

Feb 28, 2023 Kazia Therapeutics raises A$7 million to fund R&D pipeline

Feb 6, 2023 After a successful $4.5 million cap raise and with cancer trial results to come, Kazia is optimistic for 2023

Jan 31, 2023 High cost of living causes a fall in retail sales: ASX up 0.22% at noon

Jan 31, 2023 ASX rose 6.2% in January: Aus shares closed the day 0.07% lower

Jan 17, 2023 Kazia Therapeutics CEO talks $4.5 million capital raise

Jan 16, 2023 Kazia Therapeutics raising $4.5 million in placement; launches SPP

Dec 20, 2022 Kazia Therapeutics exploring use of lead asset in other cancers: Edison Investment Research

Dec 14, 2022 Kazia Therapeutics files patent as it continues to work with QIMT on cancer research